decemb
world
health
organ
inform
cluster
case
pneumonia
unknown
etiolog
wuhan
china
subsequ
investig
identifi
novel
coronaviru
name
sever
acut
respiratori
syndrom
coronaviru
affect
patient
highli
sensit
specif
laboratori
diagnost
import
control
rapidli
evolv
coronaviru
diseas
epidem
studi
develop
compar
perform
three
novel
realtim
revers
transcriptionpcr
rtpcr
assay
target
rnadepend
rna
polymeras
rdrp
helicas
hel
spike
nucleocapsid
n
gene
report
assay
use
european
laboratori
among
three
novel
assay
assay
lowest
limit
detect
vitro
tissu
cultur
infect
dose
tcid
ml
genom
rna
rna
copiesreact
vitro
rna
transcript
among
specimen
patient
laboratoryconfirm
hong
kong
posit
assay
assay
posit
addit
specimen
versu
p
includ
respiratori
tract
specimen
nonrespiratori
tract
specimen
mean
viral
load
specimen
rna
copiesml
rang
rna
copiesml
assay
crossreact
humanpathogen
coronavirus
respiratori
pathogen
cell
cultur
clinic
specimen
wherea
assay
crossreact
sarscov
cell
cultur
highli
sensit
specif
assay
may
help
improv
laboratori
diagnosi
keyword
coronaviru
diagnost
emerg
pcr
sar
wuhan
viru
n
decemb
world
health
organ
inform
cluster
case
pneumonia
unknown
etiolog
wuhan
hubei
provinc
china
http
wwwwhointwesternpacificemergenciescovid
subsequ
investig
identifi
novel
coronaviru
close
relat
sever
acut
respiratori
syndrom
coronaviru
sarscov
patient
new
viru
recent
name
sever
acut
respiratori
syndrom
coronaviru
coronaviru
studi
group
intern
committe
taxonomi
virus
patient
infect
coronaviru
diseas
present
acut
onset
fever
myalgia
cough
dyspnea
radiolog
evid
groundglass
lung
opac
compat
atyp
pneumonia
howev
asymptomat
mildli
symptomat
case
also
report
initi
epidemiolog
investig
indic
huanan
seafood
wholesal
market
wuhan
geograph
link
sourc
subsequ
detail
epidemiolog
assess
reveal
earli
case
symptom
onset
januari
link
market
persontoperson
transmiss
among
close
famili
contact
health
care
worker
includ
without
travel
histori
wuhan
report
therefor
clinic
featur
epidemiolog
link
wuhan
alon
reliabl
establish
diagnosi
evidenc
previou
epidem
caus
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
highli
sensit
specif
laboratori
diagnost
essenti
case
identif
contact
trace
anim
sourc
find
ration
infect
control
measur
use
viral
cultur
establish
acut
diagnosi
practic
take
least
day
caus
obviou
cytopath
effect
select
cell
line
cell
moreov
isol
viru
requir
biosafeti
level
facil
avail
health
care
institut
serum
antibodi
antigen
detect
test
yet
valid
may
crossreact
sarscov
share
high
degre
nucleotid
ident
limit
revers
transcriptionpcr
rtpcr
remain
use
laboratori
diagnost
test
worldwid
avail
complet
genom
earli
epidem
facilit
develop
specif
primer
standard
laboratori
protocol
protocol
first
realtim
rtpcr
assay
target
rnadepend
rna
polymeras
rdrp
envelop
e
nucleocapsid
n
gene
publish
januari
among
assay
rdrp
assay
highest
analyt
sensit
rna
copiesreact
detect
probabl
publish
rdrp
assay
probe
pan
sarbecoprob
would
detect
sarscov
bat
sarsrel
coronavirus
wherea
probe
term
assay
present
studi
report
specif
detect
sarscov
notabl
assay
design
valid
use
synthet
nucleic
acid
technolog
absenc
avail
isol
origin
patient
specimen
report
rdrp
assay
implement
laboratori
europ
studi
develop
novel
highli
sensit
specif
realtim
rtpcr
assay
compar
perform
establish
assay
use
vitro
patient
specimen
clinic
evalu
use
differ
type
clinic
specimen
patient
laboratoryconfirm
show
novel
assay
target
differ
region
rdrphel
significantli
sensit
specif
assay
virus
clinic
specimen
isol
patient
laboratoryconfirm
hong
kong
viral
isol
amplifi
one
addit
passag
cell
make
work
stock
viru
tissu
cultur
infect
dose
tcid
ml
vitro
specif
evalu
archiv
laboratori
cultur
isol
n
humanpathogen
coronavirus
respiratori
virus
use
obtain
depart
microbiolog
univers
hong
kong
previous
describ
experiment
protocol
involv
live
sarscov
merscov
follow
approv
standard
oper
procedur
biosafeti
level
facil
previous
describ
clinic
evalu
studi
total
respiratori
tract
nonrespiratori
tract
clinic
specimen
collect
patient
laboratoryconfirm
hong
kong
whose
nasopharyng
aspirateswab
throat
swab
andor
sputum
specimen
test
posit
rna
assay
addit
total
nucleic
acid
extract
archiv
store
use
nasopharyng
aspiratesswab
throat
swab
collect
adult
patient
manag
hospit
hong
kong
upper
andor
lower
respiratori
tract
symptom
test
posit
respiratori
pathogen
filmarray
biofir
diagnost
salt
lake
citi
ut
usa
prepar
accord
manufactur
instruct
assess
potenti
crossreact
assay
respiratori
pathogen
clinic
specimen
studi
approv
institut
review
board
univers
hong
konghospit
author
uw
nucleic
acid
extract
total
nucleic
acid
tna
extract
clinic
specimen
laboratori
cell
cultur
viral
isol
perform
use
nuclisen
easymag
extract
system
franc
accord
manufactur
instruct
previous
describ
volum
specimen
use
extract
elut
volum
depend
specimen
type
avail
amount
specimen
gener
l
respiratori
tract
specimen
urin
sampl
rectal
swab
fece
subject
extract
elut
volum
l
l
plasma
specimen
subject
extract
elut
volum
l
extract
store
use
extract
product
specimen
use
rtpcr
primer
probe
primer
probe
set
target
differ
gene
region
rdrphelicas
hel
spike
n
design
test
probe
predict
specif
detect
homolog
human
humanpathogen
coronavirus
microbi
gene
blastn
analysi
would
potenti
produc
falseposit
test
result
previous
describ
primer
probe
set
best
amplif
perform
select
vitro
rna
transcript
make
posit
control
standard
linear
plasmid
invitrogen
carlsbad
ca
usa
promot
clone
target
region
rdrphel
n
use
vitro
rna
transcript
use
megascript
transcript
kit
ambion
austin
tx
usa
standard
limit
detect
lod
previous
describ
linear
plasmid
templat
mix
l
atp
gtp
ctp
utp
reaction
buffer
enzym
mix
standard
reaction
mixtur
reaction
mixtur
incub
h
follow
addit
l
turbo
dnase
incub
min
synthes
rna
clean
rneasi
minikit
qiagen
hilden
germani
accord
manufactur
instruct
concentr
purifi
rna
quantifi
biodrop
lite
biodrop
uk
realtim
rtpcr
assay
rna
detect
perform
use
quantinova
probe
rtpcr
kit
qiagen
lightcycl
realtim
pcr
system
roch
basel
switzerland
previous
describ
reaction
mixtur
contain
l
quantinova
probe
rtpcr
master
mix
l
qn
probe
rtmix
l
forward
revers
primer
l
probe
l
rnasefre
water
l
tna
templat
thermal
cycl
condit
min
revers
transcript
min
pcr
initi
activ
cycl
assay
perform
previous
describ
statist
analysi
fisher
exact
test
use
compar
perform
assay
p
valu
consid
statist
signific
data
analyz
graphpad
prism
softwar
graphpad
softwar
inc
design
novel
realtim
rtpcr
assay
target
differ
gene
region
genom
three
novel
realtim
rtpcr
assay
target
rdrphel
n
gene
develop
see
tabl
supplement
materi
avoid
crossreact
human
sarscov
purpos
design
probe
assay
contain
nucleotid
differ
human
sarscov
strain
see
fig
supplement
materi
comparison
probe
assay
contain
nucleotid
differ
human
sarscov
strain
fig
determin
analyt
sensit
assay
first
evalu
lod
use
viral
genom
rna
extract
cultur
lysat
clinic
specimen
serial
dilut
rna
extract
cultur
lysat
prepar
test
triplic
correspond
assay
two
independ
run
lod
ml
lod
log
unit
higher
tcid
ml
tabl
serial
dilut
rna
extract
laboratoryconfirm
patient
nasopharyng
aspir
also
prepar
test
triplic
correspond
assay
two
independ
run
lod
fold
dilut
log
unit
lower
fold
dilut
tabl
basi
result
select
assay
evalu
determin
lod
use
vitro
viral
rna
transcript
tabl
lod
assay
use
serial
dilut
vitro
viral
rna
transcript
calcul
probit
analysi
rna
copiesreact
confid
interv
rna
copiesreact
rna
copiesreact
confid
interv
copiesreact
respect
compar
perform
detect
rna
differ
type
clinic
specimen
basi
lower
lod
assay
compar
lod
assay
evalu
perform
assay
detect
rna
clinic
specimen
compar
assay
total
respiratori
tract
nasopharyng
aspiratesswab
throat
swab
saliva
sputum
specimen
nonrespiratori
tract
specimen
plasma
urin
specimen
fecesrect
swab
collect
patient
laboratoryconfirm
hong
kong
posit
nasopharyng
aspirateswab
throat
swab
sputum
specimen
assay
median
number
specimen
collect
per
patient
patient
consist
male
femal
median
age
year
rang
year
clinic
featur
compat
acut
communityacquir
atyp
pneumonia
radiolog
evid
groundglass
lung
opac
time
write
report
patient
stabl
condit
critic
condit
patient
succumb
among
specimen
collect
patient
posit
assay
tabl
novel
assay
posit
specimen
addit
assay
posit
anoth
specimen
posit
specimen
total
specimen
versu
posit
specimen
total
specimen
p
includ
respiratori
tract
specimen
nonrespiratori
tract
specimen
neg
assay
addit
posit
specimen
confirm
posit
lightmix
modular
sar
wuhan
cov
egen
kit
lightcycl
multiplex
rna
viru
master
mean
viral
load
specimen
rna
copiesml
rang
rna
copiesml
sixfold
higher
respiratori
tract
specimen
rna
copiesml
nonrespiratori
tract
specimen
rna
copiesml
assay
significantli
sensit
assay
detect
rna
nasopharyng
aspiratesswab
throat
swab
p
saliva
p
plasma
p
specimen
shown
fig
assay
consist
detect
rna
sampl
higher
sensit
assay
throughout
patient
cours
ill
day
nasopharyng
aspiratesswab
andor
throat
swab
day
saliva
sensit
two
assay
differ
significantli
sputum
specimen
fecesrect
swab
genom
highli
similar
human
sarscov
overal
nucleotid
ident
rtpcr
assay
target
gene
fragment
homolog
virus
tabl
crossreact
virus
found
either
assay
unlik
previous
report
found
assay
crossreact
sarscov
cultur
lysat
crossreact
consist
observ
two
independ
run
conduct
differ
day
run
three
technic
replic
biolog
replic
two
biolog
replic
sarscov
strain
stringent
complianc
publish
protocol
investig
whether
assay
specif
clinic
specimen
use
assay
test
archiv
nasopharyng
aspir
swab
throat
swab
posit
respiratori
pathogen
filmarray
patient
upper
andor
lower
respiratori
tract
symptom
shown
tabl
none
specimen
posit
assay
suggest
assay
specif
detect
rna
nasopharyng
aspiratesswab
throat
swab
contain
dnarna
humanpathogen
coronavirus
respiratori
pathogen
positivesens
singlestrand
rna
genom
kb
size
encod
amino
acid
like
betacoronavirus
genom
arrang
order
spike
envelop
e
membran
nucleocapsid
n
poli
tradit
prefer
target
coronaviru
rtpcr
assay
includ
conserv
andor
abundantli
express
gene
structur
n
gene
nonstructur
rdrp
replicas
open
read
frame
orf
gene
protocol
number
rtpcr
assay
use
differ
institut
recent
made
avail
onlin
http
technicalguidancelaboratoryguid
assay
target
rdrp
e
n
gene
nonspecif
assay
would
detect
relat
betacoronavirus
sarscov
importantli
inus
evalu
data
assay
use
larg
number
clinic
specimen
patient
confirm
lack
studi
develop
evalu
three
novel
realtim
rtpcr
assay
target
differ
gene
region
genom
show
novel
assay
highli
sensit
specif
detect
rna
vitro
patient
specimen
among
three
assay
develop
studi
assay
lowest
lod
vitro
viral
rna
transcript
rna
copiesreact
confid
interv
rna
copiesreact
lod
genom
rna
also
low
tcid
ml
importantli
assay
significantli
sensit
p
establish
assay
detect
rna
respiratori
tract
nonrespiratori
tract
clinic
specimen
assay
detect
rna
addit
specimen
test
neg
assay
find
clinic
epidemiolog
relev
asymptomat
mildli
symptomat
case
increasingli
recogn
patient
cryptic
pneumonia
may
serv
potenti
sourc
propag
epidem
given
larg
number
patient
case
china
time
write
involv
expand
epidem
addit
posit
specimen
detect
assay
might
translat
thousand
specimen
would
otherwis
consid
neg
lesssensit
assay
regard
differ
type
clinic
specimen
assay
significantli
sensit
assay
detect
rna
nasopharyng
aspiratesswab
throat
swab
saliva
specimen
plasma
specimen
falseneg
result
might
aris
test
nasopharyng
aspirateswab
throat
swab
low
viral
load
sar
mer
patient
rtpcr
assay
higher
sensit
hel
assay
might
help
reduc
falseneg
rate
among
specimen
frequent
specimen
avail
establish
diagnosi
previous
shown
saliva
high
concord
rate
nasopharyng
aspir
detect
influenza
viral
rna
might
also
suitabl
specimen
diagnos
use
highli
sensit
assay
test
saliva
specimen
suspect
case
might
simpl
rapid
way
avoid
need
aerosolgener
procedur
collect
nasopharyng
aspir
suction
sputum
especi
region
heavili
affect
ongo
outbreak
insuffici
suppli
full
person
protect
equip
rnaemia
report
small
proport
patient
howev
shown
clinic
evalu
assay
gave
neg
test
result
plasma
specimen
gave
posit
test
result
assay
genuin
incid
rnaemia
might
underestim
less
sensit
rtpcr
assay
previous
shown
high
serum
viral
load
sar
patient
associ
sever
diseas
evidenc
higher
incid
oxygen
desatur
need
mechan
ventil
hepat
dysfunct
death
thu
serial
monitor
plasma
viral
load
patient
highli
sensit
assay
consid
provid
prognost
insight
facilit
treatment
decis
assay
highli
specif
exhibit
crossreact
common
respiratori
pathogen
vitro
nasopharyng
aspir
interestingli
evalu
show
assay
crossreact
sarscov
vitro
differ
previous
report
postul
might
due
small
number
n
nucleotid
differ
probe
use
assay
least
three
strain
sarscov
crossreact
would
especi
import
laboratori
area
sarscov
might
reemerg
cocircul
differ
clinic
progress
sar
remain
incomplet
understood
stage
main
limit
studi
assay
perform
use
differ
commerci
avail
reagent
primerprob
concentr
cycl
condit
made
challeng
determin
root
differ
sensit
nevertheless
data
show
newli
establish
assay
highli
sensit
specif
detect
rna
vitro
respiratori
nonrespiratori
tract
clinic
specimen
use
novel
rtpcr
assay
might
especi
use
detect
case
low
viral
load
test
upper
respiratori
tract
saliva
plasma
specimen
patient
develop
multiplex
assay
simultan
detect
humanpathogen
coronavirus
respiratori
pathogen
may
increas
clinic
util
futur
us
provision
patent
applic
file
find
studi
jasper
fw
chan
receiv
travel
grant
pfizer
corpor
hong
kong
astella
pharma
hong
kong
corpor
limit
invit
speaker
gilead
scienc
hong
kong
limit
author
declar
conflict
interest
fund
sourc
sponsor
role
design
conduct
studi
collect
analysi
interpret
data
prepar
review
approv
manuscript
